- World Alzheimer’s Day
- NHMRC-ARC Dementia Research Development Fellow Profile
- What’s on in Dementia
- Call for Papers
- Share your story
World Alzheimer’s Day – 21 September 2016
World Alzheimer’s Day is an opportune time to reflect on your research efforts and realise the importance of your work as researchers. There are 353,800 people living with dementia in Australia and a further 1.2million people involved in their care. The research and translation work enabled through the Institute aims to improve prevention, diagnosis, treatment and care for dementia patients, their carers and communities.
During World Alzheimer’s Day and throughout September Alzheimer’s Australia raises awareness about Alzheimer’s and dementia by holding a number of events featuring International and Australian dementia experts. For information on what is happening in your local area select your relevant state or territory.
As a part of Dementia Awareness Month, Alzheimer’s Australia is hosting a speaking tour featuring Dr Ronald Petersen. Dr Petersen is the Director of the U.S. Mayo Alzheimer’s Disease Research Centre, the Mayo Clinic Study on Aging and a member of the World Dementia Council. He has authored over 700 peer-reviewed articles and edited five books on memory disorders, ageing, and Alzheimer’s disease. Dr Petersen was Ronald Reagan’s personal physician and treated the former President of America’s Alzheimer’s disease. More information on dates and locations for the speaking tour can be found here. Dr Petersen will be speaking in Canberra with Ita Buttrose on 21 September at the National Press Club of Australia. For those that cannot attend, it will be nationally televised at 12.30pm AEST on ABC 1, ABC 2 and Sky.
Dr Mojtaba Golzan, NHMRC-ARC Dementia Research Development Fellow, University of Technology Sydney
Dr Golzan is an NHMRC-ARC dementia research fellow with research expertise in ocular imaging techniques, mechanical and structural properties of retinal vessels and modeling dynamic physiological interactions between the eye and the brain.
Having recently established a Vision Science research group at the University of Technology Sydney (UTS), Dr Golzan’s research focus is to investigate retinal changes during the course of dementia with a specific interest in Alzheimer’s disease (AD). His findings so far have demonstrated a significant association between retinal hemodynamics and cerebral amyloid burden in an elderly preclinical AD cohort. Furthermore, his research has demonstrated a deposition of amyloid beta (Ab) plaques in the retina of a mouse model of AD. During his fellowship, he will assess which structural, functional and/or vascular properties in the retina undergo pathological changes, and whether the progression of AD is associated with exacerbation of these changes.
Dr Golzan and his colleagues will also study the role of trans-synaptic degeneration in Aβ plaque load in the brain and whether intraocular administration of agents that target Aβ formation will delay AD-related pathology in the brain. Dr Golzan hopes that his findings may ultimately determine the diagnostic potential of eye examinations in AD and provide insight into the utility of retinal biomarkers in pre-symptomatic AD.
We wish Dr Golzan all the best with his research efforts!
What’s on in Dementia
This section highlights activities or events that may be of interest:
Quality dementia care: what do we value?
Alzheimer’s Australia Dementia Research Foundation invites you to attend a free, public panel discussion event on Wednesday 21 September 2016, in Canberra.
Join Dr Norman Swan (Host, ABC Radio National’s Health Report) and an expert panel as they discuss meeting the care needs of people living with a diagnosis of dementia and their carers, how we can measure the quality of dementia care and work towards a national set of quality indicators and, importantly, ways that we may improve the quality of dementia care now and into the future.
- Dr Ron Petersen, Director of the Mayo Alzheimer’s Disease Research Center and the Mayo Clinic Study on Aging in the U.S.
- Professor Susan Kurrle, Geriatrician and Director of the Cognitive Decline Partnership Centre
- Professor Elizabeth Beattie, Director of the Dementia Collaborative Research Centre – Carers and Consumers
- Ms Therese Adami, Chief Operating Officer of KinCare
- Ms Maree McCabe, Chief Executive Officer of Alzheimer’s Australia
- Mr Trevor Crosby, living with a diagnosis of dementia and member of the Alzheimer’s Australia Dementia Advisory Committee
There will be time following the discussion for the audience to ask our panelists questions and engage in this most important debate.
Venue: National Library of Australia
Date: Wednesday 21 September 2016
Time: 5.15pm arrival for a 6.00pm start (light refreshments from 5.15pm)
To register your place visit the Eventbrite page.
Alzheimer's Australia Dementia Research Foundation 2016 Dementia Grants Program Round 2 now open
Four PhD Scholarships of $30,000 per year over three years are on offer in Round 2, 2016.
- Three AADRF PhD Scholarships
- One Consumer Priority PhD Scholarship
Applications close Monday 17 October 2016, 5.00pm AEDT. For more information please visit the AADRF website.
The Alzheimer’s Australia Memory Walk and Jog Fundraiser
The Alzheimer’s Australia Memory Walk and Jog Fundraiser is taking place across Australia in an effort to raise funds and awareness for Dementia. To find a walk close to you of for more information visit: http://www.memorywalk.com.au/
To submit your event, send the event details to firstname.lastname@example.org
Call for Papers
Have you published a research paper on dementia lately? Have you just had a paper accepted for publication? Let us know and we’ll include a link to it in our next issue! Simply send a link to your paper to email@example.com
Share your story
If you have a story to share on dementia, whether its research or personal experience, please contact firstname.lastname@example.org or phone 02 6217 9172. Your story may be published in the next newsletter, or used as vignettes in Institute-related communication materials, or created into a feature story and pitched to the media.